ASTM E3042 - 16 - Standard Practice for Process Step to Inactivate Rodent Retrovirus with Triton X-100 Treatment

ASTM E3042 - 16

Standard Practice for Process Step to Inactivate Rodent Retrovirus with Triton X-100 Treatment

Status : Current   Published : September 2016

Format
PDF

Format
HARDCOPY



1.1 This practice assures effective inactivation of 4 log 10 of infectious rodent retrovirus (that is, reduction from 10 000 to 1 infectious rodent retrovirus or removal of 99.99 % of infectious rodent retroviruses) in the manufacturing processes of monoclonal antibodies or immunoglobulin G (IgG) Fc fusion proteins manufactured in rodent-derived cell lines that do not target retroviral antigens. Rodent retrovirus is used as a model for rodent cell substrate endogenous retrovirus-like particles potentially present in the production stream of these proteins.

1.2 The parameters specified for this practice are clarification, Triton X-100 detergent concentration, hold time, pH, and inactivation temperature.

1.3 This practice can be used in conjunction with other clearance or inactivation unit operations that are orthogonal to this inactivation mechanism to achieve sufficient total process clearance or inactivation of rodent retrovirus.

1.4 This detergent inactivation step is performed on a clarified, cell-free intermediate of the monoclonal antibody or IgG Fc fusion protein.

1.5 The values stated in SI units are to be regarded as standard. No other units of measurement are included in this standard.

1.6  This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use.




Standard NumberASTM E3042 - 16
TitleStandard Practice for Process Step to Inactivate Rodent Retrovirus with Triton X-100 Treatment
StatusCurrent
Publication Date01 September 2016
Normative References(Required to achieve compliance to this standard)No other standards are normatively referenced
Informative References(Provided for Information)No other standards are informatively referenced
Descriptors Biological pharmaceutical drug substance, Biopharmaceutical manufacturing, Detergent inactivation, Enveloped virus, IgG Fc fusion protein, Loginf10/inf reduction value, Modular viral clearance, Monoclonal antibody, Recombinant protein, Retrovirus, Triton X-100, Viral clearance, Viral inactivation
ICS07.100.01
PublisherASTM
FormatA4
DeliveryYes
Pages4
File Size74 KB
Price£36.00


 Your basket
Your basket is empty

Multi-user access to over 3,500 medical device standards, regulations, expert commentaries and other documents


Develop a PAS

Develop a fast-track standardization document in 9-12 months


Tracked Changes

Understand the changes made to a standard with our new Tracked Changes version


BSOL

The faster, easier way to work with standards